← FDA Drug Approvals (Drugs@FDA)
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDUSTRIES · Approved 2023-08-11
Drug application
- FDA Application #
ANDA214737- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
- Generic name
- Buprenorphine Hydrochloride
- Active ingredients
- BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- SUN PHARM INDUSTRIES
- First approval
- 2023-08-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown